NCT06928207View on ClinicalTrials.gov

Private Medicine Retailer-based Trial of Malaria Tests and Conditional Treatment Subsidies Among Patients With Fever

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Malaria Falciparum
Interventions
COMBINATION_PRODUCT

Provide the diagnostic (RDT) for free to clients suspected of having malaria and provide a subsidized ACT to only those testing positive

To promote the use of the recommended first line drug, we implement a conditional subsidy. The retail provider is given the malaria diagnostic for free and is instructed to test clients suspected of having malaria. Only if the test is positive, the provider is instructed to provide the ACT at a low cost.

Trial Locations (1)

Unknown

Private Medicine Retailers, Igabi and Kajuru LGA

All Listed Sponsors
lead

Clinton Health Access Initiative Inc.

OTHER

NCT06928207 - Private Medicine Retailer-based Trial of Malaria Tests and Conditional Treatment Subsidies Among Patients With Fever | Biotech Hunter | Biotech Hunter